VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH CML 2022 | The role of the bone marrow microenvironment in initiation and progression of CML

Daniela Krause, MD, Georg-Speyer-Haus, Goethe University, Frankfurt, Germany, emphasizes the important role of the bone marrow microenvironment in chronic myeloid leukemia (CML), highlighting the possibility of developing drugs that target the microenvironment to augment the efficacy of available tyrosine kinase inhibitors (TKIs). This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Research Support from Merck KGaA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter